-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NXSCN3DAIfLzXEUlyq2F9sMIcIbbTq4Vdxls0yw+Ec9ZTplzLYDHcAw9lwPP7TII +GzBdJweVJ43L+YI5KE7kw== 0001181431-09-055676.txt : 20091208 0001181431-09-055676.hdr.sgml : 20091208 20091208192529 ACCESSION NUMBER: 0001181431-09-055676 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091207 FILED AS OF DATE: 20091208 DATE AS OF CHANGE: 20091208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seely Lynn CENTRAL INDEX KEY: 0001327111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 091229756 MAIL ADDRESS: STREET 1: 501 2ND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd259205.xml 12/07/2009 EXERCISE AND SALE X0303 4 2009-12-07 0 0001011835 MEDIVATION, INC. MDVN 0001327111 Seely Lynn C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Medical Officer Common Stock 2009-12-07 4 M 0 18000 3.6 A 18000 D Common Stock 2009-12-07 4 S 0 18000 33.27 D 0 D Stock Option (Right to Buy) 3.6 2009-12-07 4 M 0 18000 0.00 D 2015-03-14 Common Stock 18000 216000 D Shares sold pursuant to a 10b5-1 Plan adopted by the Reporting Person on September 22, 2008. The shares were sold at prices between $33.11 and $33.45. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The option is immediately exercisable, in whole or in part, and the shares subject to the option vest according to the following schedule: 25% of the shares subject to the option vested on March 14, 2006, and 1/48th of the shares subject to the option vested and continue to vest on the first day of each full month thereafter so that all of the shares subject to the option shall be fully vested on March 1, 2009 /s/ Patrick Machado, Attorney-in-fact 2009-12-08 -----END PRIVACY-ENHANCED MESSAGE-----